A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
National Cancer Institute (NCI)
Artios Pharma Ltd
Novartis
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Frontier Medicines Corporation
Beijing Biotech
GI Innovation, Inc.
Hoffmann-La Roche
Merck Sharp & Dohme LLC
PMV Pharmaceuticals, Inc
Mayo Clinic
University of Southern California
Crinetics Pharmaceuticals Inc.
Verastem, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Baptist Health South Florida
M.D. Anderson Cancer Center
Ipsen
Pfizer
Eikon Therapeutics
Ascendis Pharma A/S
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc.
Crescent Biopharma, Inc.
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Incyte Corporation
M.D. Anderson Cancer Center
ModernaTX, Inc.
Memorial Sloan Kettering Cancer Center
ALX Oncology Inc.
DualityBio Inc.
Kidney Cancer Research Bureau
Ascendis Pharma A/S
Second Life Therapeutics
Rigshospitalet, Denmark
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Tyra Biosciences, Inc
Daiichi Sankyo
Pfizer
OHSU Knight Cancer Institute
Hoffmann-La Roche